The Department of Human Services shall, as part of the fiscal year 2024 Drug Overdose Prevention Program, make all FDA-approved formulations of naloxone that are cleared through the Minnesota Multistate Contracting Alliance for Pharmacy, and for which the manufacturer can set up a system for receiving, tracking, and distribution, available to eligible Drug Overdose Prevention Program participants and applicants.
305 ILCS 65/15
Availability of naloxone formulations
Known as the Early Mental Health and Addictions Treatment Act
The act spans §§ 305–305 (5 sections).
P.A. 103-8, eff. 6-7-23.
Official source: Illinois General Assembly. Reproduced from public-domain Illinois statutes; confirm against the official source for the current text. Not legal advice.